Clinical Findings and Prognosis of COVID-19 Patients with Benign Prostatic Hyperplasia: A Case Series

Sepideh Babaniamansour; Ahmadreza Atarodi; Parto Babaniamansour; Mohammad Dehghani Firouzabadi; Mohammadreza Majidi; Sepideh Karkon-Shayan*

Sepideh Babaniamansour, Ahmadreza Atarodi, Parto Babaniamansour, Mohammad Dehghani Firouzabadi, Mohammadreza Majidi and Sepideh Karkon-Shayan*

Volume2-Issue5
Dates: Received: 2021-04-16 | Accepted: 2021-05-19 | Published: 2021-05-20
Pages: 328-332

Abstract

Coronavirus Disease (COVID-19) is accompanied by high comorbidities and a worse prognosis in those with underlying diseases. Older men are more vulnerable to COVID-19 infection and Benign Prostatic Hyperplasia (BPH) accounts for a large portion of this population, so this study presented the clinical and paraclinical features of 20 COVID-19 patients with BPH and their outcome. The mean age of participants was 76.8 ± 7.9 years. Respiratory symptoms are the most common complaints and Ground glass and opacities infiltration were the most frequent findings in the chest computed tomography. Mostly the level of C-reactive protein and lactate dehydrogenase were high, but hemoglobin and lymphocyte count were low. They underwent standard management and all were discharged and stayed alive in the one-month follow-up. Besides the high prevalence of BPH and high mortality rate of COVID-19 in older men, the present study showed that COVID-19 patients with BPH had a good prognosis.

FullText HTML FullText PDF DOI: 10.37871/jbres1236

Certificate of Publication

Copyright

How to cite this article

Babaniamansour S, Atarodi A, Babaniamansour P, Firouzabadi MD, Majidi M, Karkon-Shayan S. Clinical Findings and Prognosis of COVID-19 Patients with Benign Prostatic Hyperplasia: A Case Series. J Biomed Res Environ Sci. 2021 May 20; 2(5): 328-332. doi: 10.37871/jbres1236, Article ID: jbres1236

Subject area(s)

Rare Disorders

Physical Therapy

References

Zali A, Sohrabi MR, Mahdavi A, Khalili N, Taheri MS, Maher A, Sadoughi M, Zarghi A, Ziai SA, Shabestari AA, Bakhshayeshkaram M, Haghighatkhah H, Salevatipour B, Abrishami A, Raoufi M, Dehghan P, Bagheri AK, Khoshnoud RJ, Hanani K. Correlation Between Low-Dose Chest Computed Tomography and RT-PCR Results for the Diagnosis of COVID-19: A Report of 27,824 Cases in Tehran, Iran. Acad Radiol. 2020 Sep 21:S1076-6332(20)30542-0. doi: 10.1016/j.acra.2020.09.003. Epub ahead of print. PMID: 33020043; PMCID: PMC7505583.
Eslami V, Abrishami A, Zarei E, Khalili N, Baharvand Z, Sanei-Taheri M. The Association of CT-measured Cardiac Indices with Lung Involvement and Clinical Outcome in Patients with COVID-19. Acad Radiol. 2021 Jan;28(1):8-17. doi: 10.1016/j.acra.2020.09.012. Epub 2020 Oct 1. PMID: 33041195; PMCID: PMC7528899.
Farzi MA, Ayromlou H, Jahanbakhsh N, Bavil PH, Janzadeh A, Shayan FK. Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report. J Neuroimmunol. 2020 Jun 20;346:577294. doi: 10.1016/j.jneuroim.2020.577294. Epub ahead of print. PMID: 32590125; PMCID: PMC7305747.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of Coronavirus Disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26. PMID: 32113704; PMCID: PMC7127067.
Firouzabadi FD, Firouzabadi MD, Ghalehbaghi B, Jahandideh H, Roomiani M, Goudarzi S. Have the symptoms of patients with COVID-19 changed over time during hospitalization? Med Hypotheses. 2020 Oct;143:110067. doi: 10.1016/j.mehy.2020.110067. Epub 2020 Jul 1. PMID: 32634735; PMCID: PMC7328546.
Dehghani Firouzabadi M, Dehghani Firouzabadi F, Goudarzi S, Jahandideh H, Roomiani M. Has the chief complaint of patients with COVID-19 disease changed over time? Med Hypotheses. 2020 Nov;144:109974. doi: 10.1016/j.mehy.2020.109974. Epub 2020 Jun 7. PMID: 32534342; PMCID: PMC7276133.
Saberian P, Mireskandari SM, Baratloo A, Hasani-Sharamin P, Babaniamansour S, Aliniagerdroudbari E, Jamshididana M. Antibody Rapid Test Results in Emergency Medical Services Personnel during COVID-19 Pandemic; a Cross Sectional study. Arch Acad Emerg Med. 2020 Nov 10;9(1):e2. doi: 10.22037/aaem.v9i1.993. PMID: 33313569; PMCID: PMC7720855.
Nouri-Vaskeh M, Sharifi A, Khalili N, Zand R, Sharifi A. Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism. Clin Neurol Neurosurg. 2020 Nov;198:106217. doi: 10.1016/j.clineuro.2020.106217. Epub 2020 Sep 9. PMID: 32947193; PMCID: PMC7480672.
Huang C, Mazdeyasna S, Mohtasebi M, Saatman KE, Cheng Q, Yu G, Chen L. Speckle contrast diffuse correlation tomography of cerebral blood flow in perinatal disease model of neonatal piglets. J Biophotonics. 2021 Apr;14(4):e202000366. doi: 10.1002/jbio.202000366. Epub 2021 Jan 3. PMID: 33295142.
Jalali A, Ehsan Karimi Alavijeh , Ehsan Aliniagerdroudbari , Sepideh Babaniamansour. Incidentally Diagnosed COVID-19 in the Emergency Department: A Case Series. Case Reports in Clinical Practice. 2021 Mar 7;5(Covid-19(2020)):p.145-148.
Topaktaş R, Tokuç E, Ali Kutluhan M, Akyüz M, Karabay E, Çalışkan S. Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in ageing male: A retrospective study of 18 cases. Int J Clin Pract. 2020 Aug;74(8):e13574. doi: 10.1111/ijcp.13574. Epub 2020 Jun 23. PMID: 32506768; PMCID: PMC7300559.
Boehm K, Ziewers S, Brandt MP, Sparwasser P, Haack M, Willems F, Thomas A, Dotzauer R, Höfner T, Tsaur I, Haferkamp A, Borgmann H. Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients’ Perspective. Eur Urol. 2020 Jul;78(1):16-20. doi: 10.1016/j.eururo.2020.04.055. Epub 2020 Apr 27. PMID: 32362498; PMCID: PMC7183955.
Kim BS, Ko YH, Song PH, Kim TH, Kim KH, Kim BH. Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study. Prostate Int. 2019 Mar;7(1):30-34. doi: 10.1016/j.prnil.2018.06.002. Epub 2018 Jun 18. PMID: 30937296; PMCID: PMC6424679.
Alireza Jalali, Ehsan Karimialavijeh, Parto Babaniamansour, Ehsan Aliniagerdroudbari, Sepideh Babaniamansour. Predicting the 30-day Adverse Outcomes of Non-Critical New-Onset COVID-19 Patients in Emergency Departments based on their Lung CT Scan Findings; A Pilot Study for Derivation an Emergency Scoring Tool. Frontiers in Emergency Medicine. 2021 Mar 28;0(0).
Mostafa Sadeghi, Peyman Saberian, Parisa Hasani-Sharamin, Fatemeh Dadashi, Sepideh Babaniamansour, Ehsan Aliniagerdroudbari. The Possible Factors Correlated with The Higher Risk of Getting Infected by COVID-19 in Emergency Medical Technicians; A Case-Control Study. Bulletin of Emergency And Trauma. 2021 Apr;9(2):67-72. doi:10.30476/BEAT.2021.89713.
Meshkat S, Salimi A, Joshaghanian A, Sedighi S, Sedighi S, Aghamollaii V. Chronic neurological diseases and COVID-19: Associations and considerations. Transl Neurosci. 2020 Sep 9;11(1):294-301. doi: 10.1515/tnsci-2020-0141. PMID: 33335769; PMCID: PMC7712023.
Sakineh Hajebrahimi, Negar Taleschian-Tabrizi, Sepideh Karkon Shayan, Fariba Pashazadeh, Sarvin Radvar, Ali Motamed-Sanaye, Amirreza Tavassoli. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A scoping review Running title: Ozone Therapy for COVID-19. 2020 Apr. doi:10.22541/au.158802287.70368740.
Ahmadiafshar A, Tabbekhha S, Mousavinasab N, Khoshnevis P. Relation between asthma and body mass index in 6-15 years old children. Acta Med Iran. 2013;51(9):615-9. PMID: 24338192.
Sahranavard M, Akhavan Rezayat A, Zamiri Bidary M, Omranzadeh A, Rohani F, Hamidi Farahani R, Hazrati E, Mousavi SH, Afshar Ardalan M, Soleiman-Meigooni S, Hosseini-Shokouh SJ, Hejripour Z, Nassireslami E, Laripour R, Salarian A, Nourmohammadi A, Mosaed R. Cardiac Complications in COVID-19: A Systematic Review and Meta-analysis. Arch Iran Med. 2021 Feb 1;24(2):152-163. doi: 10.34172/aim.2021.24. PMID: 33636985.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. Chinese. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. PMID: 32064853.
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramírez-Vallejo E, Suárez JA, Zambrano LI, Villamil-Gómez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar-Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13. PMID: 32179124; PMCID: PMC7102608.
La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D. Int J Mol Sci. 2020 Apr 22;21(8):2948. doi: 10.3390/ijms21082948. PMID: 32331343; PMCID: PMC7215653.
Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M, Chen T, Song S, Ma Z, Chen X, Zheng R, Cao Q, Wang F, Zhang Y. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020 Mar 16:ciaa270. doi: 10.1093/cid/ciaa270. Epub ahead of print. PMID: 32173725; PMCID: PMC7184444.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091. Erratum in: BMJ. 2020 Mar 31;368:m1295. PMID: 32217556; PMCID: PMC7190011.
Pozzilli P, Lenzi A. Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic. Metabolism. 2020 Jul;108:154252. doi: 10.1016/j.metabol.2020.154252. Epub 2020 Apr 27. PMID: 32353355; PMCID: PMC7185012.
Salahshour F, Mehrabinejad MM, Nassiri Toosi M, Gity M, Ghanaati H, Shakiba M, Nosrat Sheybani S, Komaki H, Kolahi S. Clinical and chest CT features as a predictive tool for COVID-19 clinical progress: introducing a novel semi-quantitative scoring system. Eur Radiol. 2021 Jan 15:1–11. doi: 10.1007/s00330-020-07623-w. Epub ahead of print. PMID: 33449185; PMCID: PMC7809225.